STATISTICAL ANALYSIS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE EXACERBATIONS IN CLINICAL STUDIES: EXPECTATIONS AND LIMITATIONS

被引:0
|
作者
Gillissen, A. [1 ]
Glaab, T. [2 ]
Lewis, M. [3 ]
Buhl, R. [2 ]
Worth, H.
机构
[1] Robert Koch Hosp, St George Med Ctr, Leipzig, Germany
[2] Univ Hosp, Dept Pulm, Mainz, Germany
[3] FISPE Epidemiol GmbH, Berlin, Germany
来源
关键词
chronic obstructive pulmonary disease; exacerbation; statistics; INHALED CORTICOSTEROIDS; LUNG-FUNCTION; FLUTICASONE PROPIONATE; COPD EXACERBATIONS; BETA-AGONISTS; MORTALITY; TIOTROPIUM; OUTCOMES; METAANALYSIS; SALMETEROL;
D O I
暂无
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Acute exacerbations of chronic obstructive pulmonary disease (COPD) occur more frequently with increasing COPD severity and are associated with increased morbidity, reduced quality of life, and increased risk of mortality. The prevention and assessment of exacerbations, as a clinically and therapeutically relevant parameter, is a central aspect of clinical COPD studies. The aim of this review is to identify pittfalls in the analysis of the parameter of exacerbation and to describe the criteria that need to be considered in the statistical analysis of exacerbation studies.
引用
收藏
页码:7 / 11
页数:5
相关论文
共 50 条
  • [1] Clinical Outcomes and Cost Analysis of Exacerbations in Chronic Obstructive Pulmonary Disease
    Miravitlles, Marc
    Garcia-Polo, Cayo
    Domenech, Adolfo
    Villegas, Gustavo
    Conget, Francisco
    de la Roza, Cristian
    LUNG, 2013, 191 (05) : 523 - 530
  • [2] Clinical Outcomes and Cost Analysis of Exacerbations in Chronic Obstructive Pulmonary Disease
    Marc Miravitlles
    Cayo García-Polo
    Adolfo Domenech
    Gustavo Villegas
    Francisco Conget
    Cristian de la Roza
    Lung, 2013, 191 : 523 - 530
  • [3] Clinical and economic analysis of antimicrobial therapy of chronic obstructive pulmonary disease exacerbations
    Simoens, S.
    Decramer, M.
    De Coster, S.
    Celis, G.
    Laekeman, G.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2007, 61 (02) : 200 - 206
  • [4] Statistical treatment of exacerbations in therapeutic trials of chronic obstructive pulmonary disease
    Suissa, S
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2006, 173 (08) : 842 - 846
  • [5] Chronic Obstructive Pulmonary Disease Exacerbations
    Gaga, M.
    EUROPEAN RESPIRATORY REVIEW, 2009, 18 (114): : 305 - 305
  • [6] Exacerbations of chronic obstructive pulmonary disease
    Kidney, J
    McManus, T
    Coyle, PV
    THORAX, 2002, 57 (09) : 753 - 754
  • [7] Exacerbations of chronic obstructive pulmonary disease
    Celli, B. R.
    Barnes, P. J.
    EUROPEAN RESPIRATORY JOURNAL, 2007, 29 (06) : 1224 - 1238
  • [8] Chronic obstructive pulmonary disease .6: The aetiology of exacerbations of chronic obstructive pulmonary disease
    White, AJ
    Gompertz, S
    Stockley, RA
    THORAX, 2003, 58 (01) : 73 - 80
  • [9] Pulmonary embolism and exacerbations of chronic obstructive pulmonary disease
    Mispelaere, D
    Glerant, JC
    Audebert, M
    Remond, A
    Sevestre-Pietri, MA
    Jounieaux, V
    REVUE DES MALADIES RESPIRATOIRES, 2002, 19 (04) : 415 - 423
  • [10] Clinical features of Japanese patients with exacerbations of chronic obstructive pulmonary disease
    Hiroki Tashiro
    Yuki Kurihara
    Koichiro Takahashi
    Hironori Sadamatsu
    Tetsuro Haraguchi
    Ryo Tajiri
    Ayako Takamori
    Shinya Kimura
    Naoko Sueoka-Aragane
    BMC Pulmonary Medicine, 20